2025 Organ Donation Congress/17th Biennial Congress of International Society for Organ Donation Professionals
Kyoto International Conference Center / December 3-6, 2025

Call for Abstract Highlights

• Submission deadline: June 9, 2025.
• Notification of acceptance: August 14, 2025.
• Registration: presenters must be registered and have paid the registration fee by September 4, 2025; otherwise, the abstract will be removed from the program.
• ONLY accepted abstracts by a presenter registered to attend the Congress will be published in an online supplement of the Transplantation Journal.
• Rule of two: one person can only present two oral abstracts during the Congress. Co-authors must be assigned as presenter if more than two abstracts were accepted for oral (details below).
• Poster presentations, as well as oral presentations are welcome.
• Resubmission policy: abstracts that have been presented at other congresses in the past year (since ISODP 2023) can be resubmitted unless a manuscript has been published in a scientific journal. Abstracts that have also been submitted to WTC 2025 or accepted at TTS 2024 are welcome.

Abstract Topics for ISODP 2025

• Artificial Intelligence / Big Data
• Basic Research / Laboratory Research
• Consent and Family Approach
• Cultural and Religion Considerations
• Death Determination / Brain Death
• Developing Donation in Low Resource Settings
• Donation after Circulatory Determination of Death (DCDD)
• Donor Detection
• Donor and Donor Family Recognition
• Donor Management
• Donation System Organisation
• Ethics and Legal Issues
• Family Care (during and after donation)
• Infection and Transmissible Diseases
• In-hospital Donor Coordination
• Living Donation
• Normothermic Regional Perfusion (NRP)
• Organ Donor and transplant Registries
• Organ Preservation and Ex-Situ Machine Perfusion
• Organ Utilization, Allocation and Extended Criteria Donor
• Public Promotion and Awareness
• Tissue Donation
• Training, Education and Professional Development
• Miscellaneous

Abstract Structure

Abstracts must be comprised of four distinct sections:

1. Introduction: Describes previous research and the rationale for the current study
2. Method: Describes how the study was conducted
3. Results: Describes the results of the study
4. Conclusion: Summarize the study and discusses its implications

Please do not insert tables into the body of the abstracts. They will need to be uploaded into jpg, png or gif as a figure.

Abstract Guidelines

All abstracts must be submitted electronically through the Congress management system.

－Abstracts should be submitted only in English and there is no fee for submission.

－The abstract text body is limited to 3,000 characters including spaces (about 400 words or more, depending on spacing). A maximum of two figures (in JPG, GIF or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure. Make sure you submit your figure with no surrounding white space and the text is readable.

－By submitting an abstract to ISODP 2025, the submitter consent to having the abstract (if accepted) published in the online supplement of the Transplantation Journal.

－Only registered presenters will have their accepted abstracts published

－It is the submitter responsibility to ensure that all co-authors approve of the abstract submission, publication, and potential presentation at ISODP 2025.

－Employees of Commercial Interests: ISODP recognizes that employees of commercial interests are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. Employees of commercial interests should submit abstracts when the content is limited to science research (e.g., pre-clinical research, drug discovery) or the processes/methodologies of research, themselves unrelated to a specific disease or compound/drug, and the abstract is not related to clinical applications of the research/discovery or clinical recommendations concerning the business lines or products/service of their employer.

－Presenting content featuring clinical recommendations aligned to business interests and/or products and services of a commercial interest organization is strictly prohibited.

Policies for Abstract Submission

Copyright Policy

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Resubmission Abstract Policy

ISODP 2025 welcomes the submission of abstracts that have been presented previously at regional, national, or international meetings in the year since the last ISODP Congress (2023). However, if a manuscript of the abstract has been published at the time of submission, the paper will not be permitted.

Plagiarism

ISODP 2025 regard plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author will be rejected. In addition, the submitting author’s profile and scholarship application, in the case one has been submitted, will also be cancelled.

Ethics Compliance

To be eligible to submit an abstract, you must disclose that the authors/scientists have not violated any aspect of The Transplantation Society Ethics statements and that this research conforms with the ethical statements noted. Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the following policy documents:

• The Declaration of Istanbul (DOI) ethics' statement
• The ethical statement on human research subject, Helsinki Declaration of The World Medical Association
• The International Xenotransplantation Association Ethics Committee Position Paper on The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003)
• The Transplantation Society (TTS) Ethics statement
• Institutional Ethical Review for human and/or animal research as appropriate

Abstract Review and Selection Process

• All submitted abstracts will go through a blinded peer-review process carried out by an international review committee.
• Abstracts which do not meet the focus of the topic category as requested by the authors will be reassigned to another category.
• Scores assigned by all reviewers are averaged. The cut-off average score for acceptance is based on available oral and poster presentations. Rejections are further evaluated by the scientific program committee.

Notification of Acceptance

Notification of acceptance or rejection will be sent to the submitting (corresponding) author by August 14, 2025. Please note that only the corresponding author will receive the communication concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

Rule of Two

Each presenting author may present a maximum of two oral abstracts at the congress (excluding invited presentations). The number of submissions and the number of poster presentations are however not limited. Should an author have more than two oral abstracts accepted, a co-author must be named as presenter or they may be presented as a poster. All presenting authors must register and attend the congress.